Insider Stock Trading History of Higgins John L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Higgins John L since year 2005. The trader's CIK number is 1208906. At the time of this reporting, Higgins John L is the Chief Executive Officer of Ligand Pharmaceuticals Inc . (stock ticker symbol LGND). See this page for all insider trading activities at Ligand Pharmaceuticals Inc .

Note that in the past HIGGINS JOHN L also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Higgins John L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-17 LGND Ligand Pharmaceuticals Inc Sale 2,258 140.34 316,887
2017-11-16 LGND Ligand Pharmaceuticals Inc Sale 5,269 142.53 750,990
2017-10-13 LGND Ligand Pharmaceuticals Inc Option Ex 11,384 21.92 249,537
2017-09-05 LGND Ligand Pharmaceuticals Inc Option Ex 5,000 21.00 105,000
2017-09-05 LGND Ligand Pharmaceuticals Inc Sale 5,000 130.00 650,000
2017-08-08 LGND Ligand Pharmaceuticals Inc Sale 5,483 125.00 685,375
2017-08-08 LGND Ligand Pharmaceuticals Inc Option Ex 5,483 21.00 115,143
2017-06-21 LGND Ligand Pharmaceuticals Inc Sale 4,666 120.00 559,920
2017-06-21 LGND Ligand Pharmaceuticals Inc Option Ex 4,666 21.00 97,986
2017-06-09 LGND Ligand Pharmaceuticals Inc Sale 12,000 114.87 1,378,440
2017-06-09 LGND Ligand Pharmaceuticals Inc Option Ex 12,000 21.00 252,000
2017-03-20 LGND Ligand Pharmaceuticals Inc Sale 4,000 109.10 436,400
2017-03-08 LGND Ligand Pharmaceuticals Inc Option Ex 15,675 10.05 157,533
2017-03-08 LGND Ligand Pharmaceuticals Inc Sale 4,000 107.06 428,240
2016-09-22 LGND Ligand Pharmaceuticals Inc Sale 3,000 117.34 352,020
2016-09-08 TECH Bio-techne Corp Sale 1,700 109.83 186,716
2016-03-08 LGND Ligand Pharmaceuticals Inc Option Ex 6,000 21.00 126,000
2016-03-07 LGND Ligand Pharmaceuticals Inc Sale 10,833 102.70 1,112,603
2015-08-06 LGND Ligand Pharmaceuticals Inc Sale 4,666 110.79 516,946
2015-06-09 LGND Ligand Pharmaceuticals Inc Sale 10,000 93.60 936,000
2014-08-15 LGND Ligand Pharmaceuticals Inc Buy 1,000 54.97 54,970
2014-02-12 LGND Ligand Pharmaceuticals Inc Sale 16,875 75.00 1,265,625
2014-02-12 LGND Ligand Pharmaceuticals Inc Option Ex 16,875 9.96 168,075
2014-01-21 LGND Ligand Pharmaceuticals Inc Option Ex 9,000 21.00 189,000
2014-01-16 LGND Ligand Pharmaceuticals Inc Sale 15,000 64.00 960,000
2013-10-18 LGND Ligand Pharmaceuticals Inc Sale 10,000 55.00 550,000
2013-10-22 LGND Ligand Pharmaceuticals Inc Option Ex 10,518 15.53 163,291
2013-08-19 LGND Ligand Pharmaceuticals Inc Option Ex 6,556 16.14 105,813
2013-08-16 LGND Ligand Pharmaceuticals Inc Sale 10,000 42.85 428,500
2012-12-05 LGND Ligand Pharmaceuticals Inc Buy 2,000 18.03 36,060
2012-08-13 LGND Ligand Pharmaceuticals Inc Buy 500 16.39 8,195
2012-05-04 LGND Ligand Pharmaceuticals Inc Buy 1,000 12.04 12,040
2010-02-17 LGND Ligand Pharmaceuticals Inc Buy 6,000 1.67 10,020
2007-08-13 LGND Ligand Pharmaceuticals Inc Buy 2,000 5.86 11,720
2007-06-15 LGND Ligand Pharmaceuticals Inc Buy 2,000 6.70 13,400
2005-06-10 CNCT Connetics Corp Sale 10,000 20.71 207,070

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Higgins John L (Chief Executive Officer of Ligand Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.